Renaissance Technologies (RenTech)'s TLSI Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 30,900 shares of TriSalus Life Sciences, Inc. (TLSI) worth $123,600, representing 0.00% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 4 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in TLSI for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 30,900 shares. Largest reduction occurred in Q2 2025, reducing 20,200 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s TriSalus Life Sciences (TLSI) Holding Value Over Time
Track share changes against reported price movement
Quarterly TriSalus Life Sciences (TLSI) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +30,900 | New Buy | 30,900 | $4.00 |
| Q2 2025 | -20,200 | Sold Out | 0 | $0.00 |
| Q1 2025 | +6,800 | Add 50.75% | 20,200 | $5.52 |
| Q4 2024 | +13,400 | New Buy | 13,400 | $5.01 |
Renaissance Technologies (RenTech)'s TriSalus Life Sciences Investment FAQs
Renaissance Technologies (RenTech) first purchased TriSalus Life Sciences, Inc. (TLSI) in Q4 2024, acquiring 13,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held TriSalus Life Sciences, Inc. (TLSI) for 4 quarters since Q4 2024.
Renaissance Technologies (RenTech)'s largest addition to TriSalus Life Sciences, Inc. (TLSI) was in Q1 2026, adding 30,900 shares worth $123,600.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 30,900 shares of TriSalus Life Sciences, Inc. (TLSI), valued at approximately $123,600.
As of the Q1 2026 filing, TriSalus Life Sciences, Inc. (TLSI) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in TriSalus Life Sciences, Inc. (TLSI) was 30,900 shares, as reported at the end of Q1 2026.